Stocksigma LogoStocksigma Logo

Gufic Biosciences Secures Strong CRISIL ESG Rating of 62

Crisil ESG Ratings & Analytics has assigned an overall rating of CRISIL ESG 62 (Category: Strong) to Gufic Biosciences Limited for FY25-26

Gufic Biosciences Secures Strong CRISIL ESG Rating of 62

Gufic Biosciences Ltd 路 Others (Uncategorized) 路 28 Sept 2026, 11:52 pm

Gufic Biosciences Secures Strong CRISIL ESG Rating of 62 Crisil ESG Ratings & Analytics has assigned an overall rating of CRISIL ESG 62 (Category: Strong) to Gufic Biosciences Limited for FY25-26. The evaluation was conducted independently based on publicly available domain information, as the company did not officially engage Crisil for the rating process. The rating report, dated 25th Sep'26, was received and disclosed by the company on 28th Sep'26 in compliance with SEBI listing regulations.

Original exchange filing (PDF)

More announcements from Gufic Biosciences Ltd

All Gufic Biosciences Ltd announcements